SMLR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SMLR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Semler Scientific's cash to debt ratio for the quarter that ended in Sep. 2024 was 145.61.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Semler Scientific could pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.
The historical rank and industry rank for Semler Scientific's Cash-to-Debt or its related term are showing as below:
During the past 13 years, Semler Scientific's highest Cash to Debt Ratio was No Debt. The lowest was 0.06. And the median was 173.53.
The historical data trend for Semler Scientific's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Semler Scientific Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Cash-to-Debt | Get a 7-Day Free Trial | No Debt | No Debt | 114.84 | 175.87 | 357.50 |
Semler Scientific Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Cash-to-Debt | Get a 7-Day Free Trial | 309.54 | 357.50 | 454.74 | 115.79 | 145.61 |
For the Medical Devices subindustry, Semler Scientific's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Semler Scientific's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Semler Scientific's Cash-to-Debt falls into.
This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.
Semler Scientific's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:
Cash to Debt Ratio | = | Cash, Cash Equivalents, Marketable Securities | / | Total Debt | ||
= | Cash, Cash Equivalents, Marketable Securities | / | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | |
= | 57.2 | / | (0.09 | + | 0.07) | |
= | 357.50 |
Semler Scientific's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:
Cash to Debt Ratio | = | Cash, Cash Equivalents, Marketable Securities | / | Total Debt | ||
= | Cash, Cash Equivalents, Marketable Securities | / | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | |
= | 12.668 | / | (0.087 | + | 0) | |
= | 145.61 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Semler Scientific (NAS:SMLR) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Thank you for viewing the detailed overview of Semler Scientific's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.
Eric Semler | director | 4625 FIELDSTON ROAD, BRONX NY 10471 |
Douglas Murphy-chutorian | director, 10 percent owner, officer: Chief Executive Officer | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112 |
Renae Cormier | officer: Chief Financial Officer | C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVE, SUITE 2344, SANTA CLARA CA 95051 |
Wayne T Pan | director | 2330 NW EVERETT STREET, PORTLAND OR 97210 |
William H.c. Chang & Diana Shon Chang Ttee Chang Family Trust U/a Dtd 10/23/2006 | 10 percent owner | C/O SEMLER SCIENTIFIC, INC., 911 BERN CT., SAN JOSE CA 95112 |
Chang 2020 Delaware Lp | 10 percent owner | C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, SUITE 2344, SANTA CLARA CA 95051 |
Arthur N Leibowitz | director | C/O I-TRAX INC, ONE LOGAN SQUARE STE 2615, PHILADELPHIA PA 19103 |
Chang 2020 Gp Llc | 10 percent owner | C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, STE. 2344, SANTA CLARA CA 95051 |
Cindy Moon | director | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SAN JOSE CA 95112 |
Daniel S Messina | director | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, STE. 110, SAN JOSE Z4 95112 |
Daniel E Conger | officer: Vice President, Finance | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112 |
William H Chang | 10 percent owner | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112 |
Diana Shon Chang | 10 percent owner | 1301 SHOREWAY RD., SUITE 150, BELMONT CA 94002 |
Andrew B. Weinstein | officer: Senior VP, Finance and Acct. | C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112 |
Herbert J Semler | director, 10 percent owner | C/O SEMLER SCIENTIFIC, INC., 2330 NW EVERETT ST., PORTLAND OR 97210 |
From GuruFocus
By PRNewswire • 07-22-2024
By GuruFocus News • 10-09-2024
By PRNewswire • 11-18-2024
By GuruFocus News • 11-05-2024
By GuruFocus Research • 09-12-2024
By Business Wire • 09-17-2024
By GuruFocus News • 12-04-2024
By PRNewswire • 08-26-2024
By GuruFocus Research • 09-18-2024
By GuruFocus Research • 09-27-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.